Fardel O[au] - Search Results

Year	Number of Results
1990	1
1992	2
1993	6
1994	4
1995	5
1996	6
1997	3
1998	5
1999	9
2000	4
2001	9
2002	9
2003	6
2004	5
2005	8
2006	8
2007	5
2008	8
2009	9
2010	5
2011	12
2012	10
2013	9
2014	6
2015	11
2016	5
2017	12
2018	15
2019	11
2020	9
2021	7
2022	1

1

Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.

Lescoat A, Lelong M, Jeljeli M, Piquet-Pellorce C, Morzadec C, Ballerie A, Jouneau S, Jego P, Vernhet L, Batteux F, Fardel O, Lecureur V. Lescoat A, et al. Among authors: fardel o. Biochem Pharmacol. 2020 Aug;178:114103. doi: 10.1016/j.bcp.2020.114103. Epub 2020 Jun 17. Biochem Pharmacol. 2020. PMID: 32562787 Free article.

2

Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.

Jaguin M, Houlbert N, Fardel O, Lecureur V. Jaguin M, et al. Among authors: fardel o. Cell Immunol. 2013 Jan;281(1):51-61. doi: 10.1016/j.cellimm.2013.01.010. Epub 2013 Feb 4. Cell Immunol. 2013. PMID: 23454681

3

Substrate-Dependent Trans-Stimulation of Organic Cation Transporter 2 Activity.

Lefèvre CR, Le Vée M, Gaubert S, Jouan E, Bruyere A, Moreau C, Fardel O. Lefèvre CR, et al. Among authors: fardel o. Int J Mol Sci. 2021 Nov 29;22(23):12926. doi: 10.3390/ijms222312926. Int J Mol Sci. 2021. PMID: 34884730 Free PMC article.

4

Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes.

Fardel O, Moreau A, Le Vée M, Denizot C, Parmentier Y. Fardel O, et al. Eur J Drug Metab Pharmacokinet. 2019 Feb;44(1):13-30. doi: 10.1007/s13318-018-0502-x. Eur J Drug Metab Pharmacokinet. 2019. PMID: 30167999 Review.

5

The P-glycoprotein multidrug transporter.

Fardel O, Lecureur V, Guillouzo A. Fardel O, et al. Gen Pharmacol. 1996 Dec;27(8):1283-91. doi: 10.1016/s0306-3623(96)00081-x. Gen Pharmacol. 1996. PMID: 9304397 Review.

6

Implication of human drug transporters to toxicokinetics and toxicity of pesticides.

Guéniche N, Bruyere A, Le Vée M, Fardel O. Guéniche N, et al. Among authors: fardel o. Pest Manag Sci. 2020 Jan;76(1):18-25. doi: 10.1002/ps.5577. Epub 2019 Sep 10. Pest Manag Sci. 2020. PMID: 31392818 Review.

7

Differential interactions of carbamate pesticides with drug transporters.

Guéniche N, Bruyere A, Ringeval M, Jouan E, Huguet A, Le Hégarat L, Fardel O. Guéniche N, et al. Among authors: fardel o. Xenobiotica. 2020 Nov;50(11):1380-1392. doi: 10.1080/00498254.2020.1771473. Epub 2020 Jun 4. Xenobiotica. 2020. PMID: 32421406 Free article.

8

Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity.

Alim K, Bruyère A, Lescoat A, Jouan E, Lecureur V, Le Vée M, Fardel O. Alim K, et al. Among authors: fardel o. Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):259-271. doi: 10.1080/17425255.2021.1862084. Epub 2021 Jan 11. Expert Opin Drug Metab Toxicol. 2021. PMID: 33292029 Review.

9

Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors.

Alim K, Moreau A, Bruyère A, Jouan E, Denizot C, Nies AT, Parmentier Y, Fardel O. Alim K, et al. Among authors: fardel o. Fundam Clin Pharmacol. 2021 Oct;35(5):919-929. doi: 10.1111/fcp.12657. Epub 2021 Mar 13. Fundam Clin Pharmacol. 2021. PMID: 33523504 Free article.

10

Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans.

Bacle A, Bouzillé G, Bruyère A, Cuggia M, Fardel O, Le Corre P. Bacle A, et al. Among authors: fardel o. Eur J Pharm Biopharm. 2021 Jul;164:36-53. doi: 10.1016/j.ejpb.2021.04.014. Epub 2021 Apr 23. Eur J Pharm Biopharm. 2021. PMID: 33895293 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results